Ketamine-like effects after recreational use of methoxetamine

Annals of Emergency Medicine

Volumn 60, Issue 1, 2012, Pages 97-99

  Hofer, Katharina E ^a   Grager, Bettina ^b   Müller, Daniel M ^c   Rauber Lüthy, Christine ^a   Kupferschmidt, Hugo ^a   Rentsch, Katharina M ^c   Ceschi, Alessandro ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b Regional Hospital   (Austria)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ARIPIPRAZOLE; CHLORPROTHIXENE; DIAZEPAM; KETAMINE; METHOXETAMINE; MIDAZOLAM; RECREATIONAL DRUG; UNCLASSIFIED DRUG;

ADULT; AGITATION; ARTICLE; ATAXIA; CASE REPORT; CLINICAL FEATURE; CONFUSION; DRUG STRUCTURE; HUMAN; HYPERTENSION; INTRAVENOUS DRUG ABUSE; LIQUID CHROMATOGRAPHY; MALE; MYDRIASIS; NYSTAGMUS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; STUPOR; TACHYCARDIA; TANDEM MASS SPECTROMETRY;

ANESTHETICS, DISSOCIATIVE; CONFUSION; CYCLOHEXANONES; CYCLOHEXYLAMINES; DYSKINESIAS; HUMANS; HYPERTENSION; KETAMINE; MALE; MYDRIASIS; NYSTAGMUS, PATHOLOGIC; STREET DRUGS; TACHYCARDIA; YOUNG ADULT;

EID: 84861070545     PISSN: 01960644     EISSN: 10976760     Source Type: Journal    
DOI: 10.1016/j.annemergmed.2011.11.018     Document Type: Article

References (15)

1. Hamilton M. Interview with a ketamine chemist. Vice. Available at: http://www.viceland.com/int/v18n2/htdocs/interview-with-ketamine-chemist-704. php. Accessed September 5, 2011.
2. Critchlow DG. A case of ketamine dependence with discontinuation symptoms. Addiction. 2006;101:1212-1213.
3. Gibbons S, Zloh M. An analysis of the "legal high" mephedrone. Bioorg Med Chem Lett. 2010;20:4135-4139.
4. Maurer HH. Chemistry, pharmacology, and metabolism of emerging drugs of abuse. Ther Drug Monit. 2010;32:544-549.
5. Mueller DM, Duretz B, Espourteille FA, et al. Development of a fully automated toxicological LC-MS(n) screening system in urine using online extraction with turbulent flow chromatography. Anal Bioanal Chem. 2011;400:89-100.
6. Zarantonello P, Bettini E, Paio A, et al. Novel analogues of ketamine and phencyclidine as NMDA receptor antagonists. Bioorg Med Chem Lett. 2011;21:2059-2063.
7. Ng SH, Tse ML, Ng HW, et al. Emergency department presentation of ketamine abusers in Hong Kong: a review of 233 cases. Hong Kong Med J. 2010;16:6-11.
8. Weiner AL, Vieira L, McKay CA, et al. Ketamine abusers presenting to the emergency department: a case series. J Emerg Med. 2000;18:447-451.
9. Dillon P, Copeland J, Jansen K. Patterns of use and harms associated with non-medical ketamine use. Drug Alcohol Depend. 2003;69:23-28.
10. Green SM. Ketamine sedation for pediatric procedures. Part 2: review and implications. Ann Emerg Med. 1990;19:1024-1046.
11. Baselt RC, Cravey RH. Disposition of Toxic Drugs and Chemicals in Man. 6th ed. Chicago, IL: Year Book Medical Publishers Inc; 2002.
12. Cook EC, Perez-Reyes M, Jeffcoat AR. Phencyclidine disposition in humans after small doses of radiolabeled drug. Fed Proc. 1983;42:2566-2569.
13. Shannon M. Methylenedioxymethamphetamine (MDMA, "ecstasy"). Pediatr Emerg Care. 2000;16:377-380.
14. Morgan CJ, Muetzelfeldt L, Curran HV. Ketamine use, cognition and psychological wellbeing: a comparison of frequent, infrequent and ex-users with polydrug and non-using controls. Addiction. 2009;104:77-87.
15. Wood D, Cottrell A, Baker SC, et al. Recreational ketamine: from pleasure to pain. BJU Int. 2011;107:1881-1884.